Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Melanoma 1Bone Neoplasms 1

Interventions

Ifosfamide 4Paclitaxel 3Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Cisplatin 2Carboplatin 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1thymoglobulin 1pembrolizumab 1palifosfamide lysine 1isophosphamide mustard 1etoposide phosphate 1durvalumab 1cabazitaxel 1Vinblastine 1Stem Cell Transplantation 1Rituximab 1Radiotherapy 1Polymerase Chain Reaction 1Mycophenolic Acid 1Moxifloxacin 1Microarray Analysis 1Melphalan 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Testicular Neoplasms × Histocompatibility Testing × Clear all
NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Mayo Clinic

Terminated
13 enrolled
DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡